Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants.
Sun D, Chen G, Dellinger RW, Duncan K, Fang JL, Lazarus P
Breast Cancer Res
2006,
8
:R50
[
Full text
]
[
PubMed
]
[
Related articles
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 2 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
PubMed Central articles that cite the above article:
1.
Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen.
Lazarus P, Blevins-Primeau AS, Zheng Y, Sun D
Ann N Y Acad Sci
2009 Feb,
1155
:99-111
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
2.
Glucuronidation of tobacco-specific nitrosamines by UGT2B10.
Chen G, Dellinger RW, Sun D, Spratt TE, Lazarus P
Drug Metab Dispos
2008 May,
36
:824-30
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
You can also
check ISI Web of Science
for additional citations (subscription required)
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 2 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.